Complete guide to mesenchymal stem cells — sources (bone marrow, adipose, umbilical cord), mechanisms, safety profile, and clinical applications in regenerative medicine.
Mesenchymal stem cells are multipotent stromal cells first identified by Alexander Friedenstein in 1970. They reside in connective tissues throughout the body — bone marrow, adipose tissue, dental pulp, placenta, and umbilical cord (Wharton's jelly). MSCs are defined by three criteria established by the International Society for Cell and Gene Therapy (ISCT): adherence to plastic, expression of surface markers CD73/CD90/CD105, and differentiation capacity into bone, cartilage, and fat cells in vitro.
Wharton's jelly-derived MSCs (WJ-MSCs) from umbilical cords offer key advantages over autologous bone marrow stem cells: (1) They are neonatal-age cells with maximal proliferative capacity and immunomodulatory potency, unaffected by donor age or disease. (2) Yields are 10–20× higher than equivalent bone marrow harvests. (3) Harvest is non-invasive — obtained from donated umbilical cords at birth. (4) WJ-MSCs have been shown to be immunologically privileged (no HLA matching needed) in published cross-matching studies, enabling allogeneic use without immunosuppression.
MSCs do not primarily work by permanently engrafting and replacing damaged cells. Modern evidence supports the paracrine hypothesis: injected MSCs secrete bioactive factors — growth factors (VEGF, HGF, FGF), immunomodulatory cytokines (TGF-β1, IL-10, PGE2), and extracellular vesicles (exosomes) — that orchestrate local tissue repair, reduce inflammation, and activate endogenous stem cells. This explains why significant functional improvements can result from relatively brief MSC treatment programmes.
Related articles: Types of Stem Cells Explained (2026 Update) | Wharton's Jelly Stem Cells: Complete Guide to Umbilical Cord MSC Therapy | Understanding Stem Cell Therapy (2026 Complete Guide)
Related treatments: Anti-Aging Stem Cell Therapy | Autoimmune Disease Stem Cell Therapy | Osteoarthritis Stem Cell Therapy